PubMed Health⌕ Search

Biomedical subjects

H Abu-Srair

Publications and source records attributed to H Abu-Srair.

4 recordsLinked to original sources

Novel and characteristic CFTR mutations in Saudi Arab children with severe cystic fibrosis.

More than 600 different CFTR (cystic fibrosis transmembrane conductance regulator) gene mutations have been identified so far that are considered to cause the fatal genetic disorder cystic fibrosis (CF). We have investigated 15 Arab children from 12 families, who were diagnosed as having CF, for mutations in the coding region and in the flanking intron sequences of the CFTR gene. Six different CFTR mutations were identified including two novel mutations, 1548delG in exon 10 and 406-2A-->G in intron 3. Prominent mutations were the splice mutation 3120 + 1G-->A (intron 16) followed by N1303K (exon 21) and 1548delG (exon 10). Most CF children were homozygotes who presented with a severe form of the disease including failure to thrive, recurrent chest infections, particularly with Pseudomonas aeruginosa, and frequent hospital admissions. Identification of the CFTR mutations facilitates molecular investigation of the disease and better understanding of its pathophysiology in Arab children, among whom CF is probably an underdiagnosed disease.

Child↗

Focal nodular hyperplasia of the liver with the lumbo-costovertebral syndrome.

Congenital lumbar hernia is uncommon in children; only 42 cases have been reported. A newborn girl with congenital superior lumbar hernia associated with lumbo-costovertebral syndrome is described. Associated features include focal nodular hyperplasia of the liver, absent right kidney and hydrocephalus.

Abnormalities, Multiple↗

Transient growth deceleration in normal short children. A potential source of bias in growth studies.

We have examined the records of 21 short children evaluated for growth hormone deficiency and found not to be deficient. Their growth velocity was evaluated for at least 6 months, both before and after testing. Without any specific therapeutic intervention, growth velocity was significantly higher after testing, as compared with before. We attribute this apparent "therapeutic" effect of testing to a selection bias, due to the fact that, in normal clinical practice, children are selected for testing immediately following a period of slow growth, and that decelerations of growth are very often transient. Studies of growth-stimulating treatments using children as their own controls should, for this reason, be interpreted with caution.

Adolescent↗